Press "Enter" to skip to content

Tag: Pfizer

Updated COVID vaccine 71% effective against hospitalization for older adults

The estimated effectiveness of the updated COVID-19 vaccine among people aged 60 and older in the Netherlands was 70.7% against hospitalization and 73.3% against intensive care unit (ICU) admission in fall and early winter 2023, according to a study published yesterday in Eurosurveillance.

Researchers at the National Institute for Public Health and the Environment and University Medical Center Utrecht parsed data on hospitalizations with admission dates from October to December to estimate the effectiveness of the XBB.1.5 Pfizer/BioNTech COVID-19 vaccine among recipients of at least one previous vaccination. The study included 2,050 hospitalized adults aged 60 and older, 14.4% of whom had received the 2023 COVID-19 vaccine.

Comments closed

Health Canada approves RSV vaccine for maternal immunization

Health Canada has approved a new vaccine geared toward protecting two groups most severely affected by the respiratory syncytial virus (RSV): newborns, who would receive antibodies through maternal immunization, and Canadians over 60.

Pfizer Canada’s bivalent vaccine, called Abrysvo, aims to prevent lower respiratory tract disease caused by the virus.

It is the first RSV vaccine in Canada approved for use in pregnancy to provide protection for infants from birth to six months of age, and the second approved for seniors aged 60 and over.

Comments closed

Canada has ‘sufficient supply’ of new COVID-19 vaccines amid ‘pandemic amnesia,’ experts say

As doctors recommend new COVID-19 vaccine doses to combat the XBB.1.5 Omicron subvariant, a mutation of COVID-19 that has continued to spread despite misconceptions that the virus is in the past, officials say Canada has sufficient supply.

Comments closed

Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase

The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday.

Comments closed

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far

As the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.

Comments closed

Appointments for new Moderna COVID-19 vaccine now available in N.S.

Appointments are now available in Nova Scotia for a new monovalent Moderna COVID-19 vaccine, which the provincial government says provides the best protection against the latest strain of the virus.

Comments closed

Pfizer’s updated COVID vaccine approved by Health Canada

Pfizer’s updated COVID-19 vaccine for the upcoming fall and winter months has been granted Health Canada approval.

Pfizer’s updated vaccine is approved for people six months and older.

Comments closed

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine

Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

Comments closed

US CDC recommends broad use of updated COVID‑19 vaccines

The U.S. Centers for Disease Control and Prevention director on Tuesday signed off on broad use of updated COVID-19 vaccines approved by the government – covering ages 6 months and up – as the country prepares to start a vaccination campaign within days.

Comments closed

Health Canada approves Moderna’s updated COVID-19 vaccine

Health Canada has approved Moderna’s updated COVID-19 vaccine for all Canadians who are six months of age and older — while two other options for fall shots remain in the regulatory pipeline.

Comments closed

New COVID shots effective against latest variant, Pfizer and Moderna say

Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA.2.86 subvariant of the coronavirus in a preclinical study in mice.

Comments closed

Will updated COVID vaccines work against latest variant? Canadian scientists monitor global research

Health Canada is currently reviewing applications for Moderna and Pfizer-BioNTech’s new mRNA vaccines, developed against the dominant XBB.1.5 variant ahead of a vaccination campaign set for the fall.

Comments closed

Updated Covid-19 vaccines are coming mid-September, officials say

Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.

Comments closed